ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,191.90
-1.23%
S&P ASX All Technology
3,746.90
-2.57%
Brent Oil
80.335
-0.35%
US Dollar vs AUD
1.62923
0.27%
Bitcoin
92,594.10
-1.99%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Carmell Corporation (CTCX)

  7. Carmell Corporation (CTCX) News

Carmell Corporation

Carmell Corporation (CTCX)

NASDAQ
0.492328
0.07223
(17.19%)
Closed 11 January 8:00AM
Delayed by 15 minutes
0.4333
-0.05903
( -11.99% )
Pre Market: 8:56PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

CTCX News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
06 January 2024
CTCX (17.19%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 December 2023
CTCX (17.19%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 December 2023
CTCX (17.19%)

CTCX Discussion

View Posts
glenn1919 glenn1919 2 weeks ago
ctcx.......................weeeeeeeeeeeeeeeeeeeeeeeeee
👍️0
declaes declaes 2 weeks ago
The volume in the past few days was telling  I hope you all got in 🤑
👍️0
Invest-in-America Invest-in-America 2 weeks ago
CTCX: Bust that damn DOLLAR!!!
👍️0
Invest-in-America Invest-in-America 2 weeks ago
CTCX: Kick that ASK!!!!!
👍️0
Invest-in-America Invest-in-America 2 weeks ago
CTCX: My E-Turd gave me BIG problems, simply tryin' to grab this rocket ship today!! I DID get a decent price, but COULD have grabbed it like an insider at the PR firm just before they launched the NEWS!!! (I know, that's illegal --- but I wish I was only age 21 right now, & workin' at "GlobeNewswire" PR desk, for example!!! E.g., "Hello, MOM, grab a bunch of CTCX for us right now!!! I'm gonna tap the PR launch button in circa 10-minutes!!!")
👍️0
tw0122 tw0122 2 weeks ago
Yes acquiring $ELAB $2.41 assets .72 +'156% 
👍️0
Invest-in-America Invest-in-America 2 weeks ago
CTCX: Good news!!
👍️0
glenn1919 glenn1919 3 weeks ago
CTCX...............https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 weeks ago
8 million shares priced at .23 for commercial launch 
👍️0
tw0122 tw0122 3 weeks ago
1.8 private placemt and up it goes .47 + 110%
👍️0
glenn1919 glenn1919 1 month ago
ctcx......https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
CTCX, new 52 week low
👍️0
glenn1919 glenn1919 3 months ago
CTCX..............................https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 months ago
.56 + 16% Run run another pump whoops might be too late lol
👍️0
Invest-in-America Invest-in-America 3 months ago
CTCX: And STILL under $2.00.

_____________________________________________________________________
I'm producing a film, "American Cars of 1908" --- tap link below for latest edition:
https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExOXVyb2N1NXVkejE5em04cDMyYnRvbDV2ejAzeHdsdmZzc2JxajQwZSZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/f1NTdkdbG4XzW/giphy.gif
👍️0
glenn1919 glenn1919 3 months ago
CTCX...................................https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 3 months ago
Oh cmon
👍️0
frans frans 3 months ago
CTCX 0.53 X 0.53
👍️0
tw0122 tw0122 3 months ago
Ok .50 now
👍️0
Monksdream Monksdream 6 months ago
CTCX under $2
👍️0
Monksdream Monksdream 6 months ago
CTCX under $2
👍️0
stock1ace1 stock1ace1 1 year ago
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

https://www.businesswire.com/news/home/20230809916251/en/Carmell-Announces-Successful-Closing-of-Merger-with-Axolotl-Biologix-and-Launch-of-a-New-Brand-Identity
👍️0
stock1ace1 stock1ace1 1 year ago
CTCX $2.90 #merger complete rsi 22 oversold macd crossover bullish

https://stockcharts.com/h-sc/ui?s=Ctcx
👍️0
AJ Freely AJ Freely 1 year ago
$CTCX - Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
Up 57% Pre-Market/ Current Price $4.74
👍️0
Monksdream Monksdream 1 year ago
Carmell Therapeutics Corp NASDAQ: CTCX*

GoSymbol lookup
*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Health Care : Biotechnology | Company profile
Carmell Therapeutics Corporation is a regenerative medicine platform company. The Company is engaged in the development of allogeneic plasma-based bioactive material (PBM) that is designed to boost innate regenerative pathways across a variety of bone and soft tissue indications. The PBM technology is licensed from Carnegie Mellon University and claims the ability to plasticize whole plasma and cross link with genipin, a derivative of the gardenia plant, to provide a controlled degradation profile in vivo. The Company’s lead product, CT-101 Bone Healing Accelerant (BHA), a biologic, is designated by the United States Food and Drug Administration (FDA) as a combination product, containing the Company’s core technology of PBM plus B Tri-Calcium Phosphate (B-TCP) an already approved medical device. The Company has FDA clearance for a Phase II-stage clinical trial designed to study accelerated healing and reduced infections in open tibia (shinbone) fractures with intramedullary rodding.
Carmell Therapeutics Corp NASDAQ: CTCX*

GoSymbol lookup
*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Health Care : Biotechnology | Company profile
Carmell Therapeutics Corporation is a regenerative medicine platform company. The Company is engaged in the development of allogeneic plasma-based bioactive material (PBM) that is designed to boost innate regenerative pathways across a variety of bone and soft tissue indications. The PBM technology is licensed from Carnegie Mellon University and claims the ability to plasticize whole plasma and cross link with genipin, a derivative of the gardenia plant, to provide a controlled degradation profile in vivo. The Company’s lead product, CT-101 Bone Healing Accelerant (BHA), a biologic, is designated by the United States Food and Drug Administration (FDA) as a combination product, containing the Company’s core technology of PBM plus B Tri-Calcium Phosphate (B-TCP) an already approved medical device. The Company has FDA clearance for a Phase II-stage clinical trial designed to study accelerated healing and reduced infections in open tibia (shinbone) fractures with intramedullary rodding.
👍️0

Your Recent History

NASDAQ
CTCX
Carmell
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads